Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Mouse GDF7 ELISA Kit (AC3564)
Cat.#: ASET-2153
Specifications
Description Mouse GDF7 ELISA Kit allows for the in vitro quantitative determination of mouse GDF7 concentrations in serum, plasma, tissue homogenates, and other biological fluids. The kit employs the sandwich enzyme immunoassay technique. Size 96T Sample Type Serum, plasma, tissue homogenates, and other biological fluids. Reactivity Mouse Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 9.375 pg/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 15.625-1000 pg/mL Assay Time 4h 30m Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-1485 Rat Vaspin ELISA Kit (AC2896) Quantitative inquiry ASET-1791 Human CAPS1 ELISA Kit (AC3202) Quantitative inquiry ASET-1822 Human CDK5R1 ELISA Kit (AC3233) Quantitative inquiry ASET-1336 Human SOX6 ELISA Kit (AC2747) Quantitative inquiry ASET-1010 Human HMGN1 ELISA Kit (AC2421) Quantitative inquiry ASET-1402 Human Nicotinic Acetylcholine Receptor alpha 7 ELISA Kit (AC2813) Quantitative inquiry ASET-1026 Human Cadherin 8 ELISA Kit (AC2437) Quantitative inquiry ASET-2235 Human PTN ELISA Kit (AC3646) Quantitative inquiry ASET-1714 Human ULK1 ELISA Kit (AC3125) Quantitative inquiry ASET-1349 Monkey Luteinizing Hormone ELISA Kit (AC2760) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket